Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

1Rare1

Rank: Treasurer [?]

Points: 4210 [?]

Votes: 79 Score: 2.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Emtnester.........An... thoughts?

posted on Dec 05, 2008 11:24AM

I wouldn't think a "Final Rejection Mailed" would simply apply to a specific claim. It would appear to me that the '584 is dead. When you read the USPTO timeline it looks like this is a final action in regards to the entire patent. Can someone please clarify?